Global Markets Eye Novo Nordisk’s Wegovy, Yen Weakness, and US Critical Minerals Push
Pharmaceutical giant Novo Nordisk is poised for a significant milestone as its CEO confirms that FDA approval for the high-dose version of its popular
Related Symbols:
USDJPY
This is a summary of the original article by thestockmarketwatch.com. To read the complete article, please visit the source website:
Read Full Article at thestockmarketwatch.comNews data provided by Marketaux. ForexSentiment.live provides this summary as a convenience with proper attribution to the original source. The full article is available at the original publisher's website.
